Artificial intelligence (AI) has helped scientists propose a promising new drug combination for DIPG brain tumours. Prof Chris Jones, Director of the Brain Tumour Research Centre of Excellence at the Institute of Cancer Research (ICR), and Dr Fernando Carceller, Paediatric Neuro-Oncology Consultant at The Royal Marsden Hospital, tell us more.
Pritesh Patel, Senior Specialist Pharmacist in Paediatric Cancer at Great Ormond Street Hospital for Children and CCLG member
Dr Alison Finch is a nurse and researcher from University College London Hospitals NHS Foundation Trust (UCLH). She explains how ambulatory care is positively impacting young people’s experiences of treatment and how a CCLG Special Interest Group has been formed to develop this care nationally.
Prof Robert Wynn, Consultant Paediatric Haematologist and Director of Bone Marrow Transplant at Royal Manchester Children’s Hospital, leads the GRANS clinical trial. He tells us how this innovative treatment is showing promising results for children with hard-to-treat leukaemia.
The Little Princess Trust (LPT) has announced 10 new research projects that will improve outcomes for children with cancer, awarded in partnership with Children’s Cancer and Leukaemia Group (CCLG).
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to the University of Oxford to find out...
The idea that everyone should be treated equally is great in principle – but is it enough? We look at the difference between equity and equality to see how it can affect young patients.
Wilf was diagnosed with stage 4 Wilms tumour in 2022 when he was six years old. His mother, Tori, shares his story.
An important resource designed to support nurses who work in the field of long-term follow-up and late effects for children and young people after cancer has been updated and expanded.
